For de patienter (n = 102) med recidiv efter 180 dage, var medianoverlevelse i gruppen, der fik topotecan + cisplatin 9, 9 mdr.
In those (n=102) with recurrence after 180 days, the median survival in the topotecan plus cisplatin arm was 9.9 months (95% C. I.: